Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael I Luster

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
In Vitro Toxicology|October 1, 2011
Benzene and Its Principal Metabolites Modulate Proinflammatory Cytokines and Growth Factors in Human Epidermal Keratinocyte CulturesJames L Wilmer, Petia P Simeonova, Dori R Germolec, et al.
FEMS Immunology and Medical Microbiology|August 31, 2007
Variation in the WBC differential count and other factors associated with reporting of herpes labialis: a population-based study of adultsChristine G Parks, Michael E Andrew, Laura A Blanciforti, et al.
Molecular and Cellular Biochemistry|August 7, 2002
Cytokine polymorphisms in silicosis and other pneumoconiosesBerran Yucesoy, Val Vallyathan, Douglas P Landsittel, et al.
Toxicology and Applied Pharmacology|September 10, 2002
Insights into the quantitative relationship between sensitization and challenge for allergic contact dermatitis reactionsAaron E Scott, Michael L Kashon, Berran Yucesoy, et al.
American Journal of Respiratory Cell and Molecular Biology|October 3, 2002
Role of tumor necrosis factor in toluene diisocyanate asthmaJoanna M Matheson, Ranulfo Lemus, Robert W Lange, et al.
Vaccine|September 7, 2005
Maternal treatment with a high dose of CpG ODN during gestation alters fetal craniofacial and distal limb development in C57BL/6 miceM Renee Prater, Victor J Johnson, Dori R Germolec, et al.
Current Protocols in Toxicology|October 10, 2012
Associating changes in the immune system with clinical diseases for interpretation in risk assessmentMichael I Luster, Dori R Germolec, Christine G Parks, et al.
Journal of Toxicology and Environmental Health. Part B, Critical Reviews|January 6, 2006
The comparative immunotoxicity of five selected compounds following developmental or adult exposureRobert W Luebke, David H Chen, Rodney Dietert, et al.
Regulatory Toxicology and Pharmacology : RTP|January 2, 2010
An alternative interpretation of, "A lifetime cancer bioassay of quinacrine administered into the uterine horns of female rats"Ernest E McConnell, Jack Lippes, Roger G Growe, et al.
Regulatory Toxicology and Pharmacology : RTP|February 15, 2015
A critical examination of the mode of action of quinacrine in the reproductive tract in a 2-year rat cancer bioassay and its implications for human clinical useJoseph K Haseman, Roger G Growe, Errol Zeiger, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
In Vitro Toxicology|October 1, 2011
Benzene and Its Principal Metabolites Modulate Proinflammatory Cytokines and Growth Factors in Human Epidermal Keratinocyte CulturesJames L Wilmer, Petia P Simeonova, Dori R Germolec, et al.
FEMS Immunology and Medical Microbiology|August 31, 2007
Variation in the WBC differential count and other factors associated with reporting of herpes labialis: a population-based study of adultsChristine G Parks, Michael E Andrew, Laura A Blanciforti, et al.
Molecular and Cellular Biochemistry|August 7, 2002
Cytokine polymorphisms in silicosis and other pneumoconiosesBerran Yucesoy, Val Vallyathan, Douglas P Landsittel, et al.
Toxicology and Applied Pharmacology|September 10, 2002
Insights into the quantitative relationship between sensitization and challenge for allergic contact dermatitis reactionsAaron E Scott, Michael L Kashon, Berran Yucesoy, et al.
American Journal of Respiratory Cell and Molecular Biology|October 3, 2002
Role of tumor necrosis factor in toluene diisocyanate asthmaJoanna M Matheson, Ranulfo Lemus, Robert W Lange, et al.
Vaccine|September 7, 2005
Maternal treatment with a high dose of CpG ODN during gestation alters fetal craniofacial and distal limb development in C57BL/6 miceM Renee Prater, Victor J Johnson, Dori R Germolec, et al.
Current Protocols in Toxicology|October 10, 2012
Associating changes in the immune system with clinical diseases for interpretation in risk assessmentMichael I Luster, Dori R Germolec, Christine G Parks, et al.
Journal of Toxicology and Environmental Health. Part B, Critical Reviews|January 6, 2006
The comparative immunotoxicity of five selected compounds following developmental or adult exposureRobert W Luebke, David H Chen, Rodney Dietert, et al.
Regulatory Toxicology and Pharmacology : RTP|January 2, 2010
An alternative interpretation of, "A lifetime cancer bioassay of quinacrine administered into the uterine horns of female rats"Ernest E McConnell, Jack Lippes, Roger G Growe, et al.
Regulatory Toxicology and Pharmacology : RTP|February 15, 2015
A critical examination of the mode of action of quinacrine in the reproductive tract in a 2-year rat cancer bioassay and its implications for human clinical useJoseph K Haseman, Roger G Growe, Errol Zeiger, et al.
Pageof 8